We're Here For You | (877) 205-6480

Press Release

More info…
Alkermes Inc. Posted on:17 Sep 10 Alkermes, Inc. (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioiddependence.

nationwide drug intervention

Posted in Drug Addiction, Nationwide Drug Intervention, Rehab Options, Substance Abuse  |  Leave a comment

Leave a reply

We’re Here For You